Progress Monitoring: Your provider should be tracking your progressnot just the number on the scale, but how you're feeling, your energy levels, and your overall health
People do best when medication is part of a broader approach that helps them build sustainable health behaviors
In SURMOUNT-1 , a 72-week Phase 3 double-blind trial in 2,539 adults with obesity (or overweight with a complication) but without diabetes, once-weekly tirzepatide produced mean weight changes of 15.0% (5 mg), 19.5% (10 mg), and 20.9% (15 mg) versus 3.1% with placebo, with 5057% of participants on the higher doses losing at least 20% of body weight
240 van EijkR.RoesK.de Greef-vanD
These are people who are not critically ill or suffering from chronic conditions, but whose weight still significantly affects their sense of well-being